III. CONCLUSION For the foregoing reasons, we determine that RPX has not shown by a preponderance of the evidence that claims 1–31 are unpatentable.
IV. ORDER It is ORDERED claims 1–31 of the ’822 patent are not held unpatentable; and FURTHER ORDERED that, because this is a Final Written Decision, parties to the proceeding seeking judicial review of the decision must comply with the notice and service requirements of 37 C.F.R. § 90.2.) This f
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.